文献速递头颈外科

宫颈非精原细胞生殖细胞肿瘤转移的外科治疗

Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases.
PubMed 文献 · Laryngoscope · 2021-01-09

手术主要涉及III、IV和Vb区,常合并胸腹部手术。结论认为选择性颈清扫安全有效,2年无病生存率和总生存率均为93%。

要点

  • 选择性颈清扫是转移性NSGCT的安全有效治疗方法
  • 多数颈部标本为成熟畸胎瘤,围手术期并发症少且多可保守处理
  • 2年无病生存率和总生存率均为93%

核心结论

  • 选择性颈清扫是管理颈部NSGCT转移的安全有效方法。

主要发现

  • 手术主要涉及淋巴结III区(67.6%)、IV区(92.6%)和/或Vb区(77.9%),63.2%同时行胸腹部NSGCT切除术。
  • 颈部标本主要显示成熟畸胎瘤(83.8%),其中69.1%为单纯型,14.7%为混合型成分。

临床怎么用

  • 对于转移性NSGCT患者,选择性颈清扫可安全有效地控制颈部病变,需注意胸腹部联合手术相关的声带麻痹和乳糜漏风险。

局限性

  • 回顾性研究,样本量有限,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/HYPOTHESIS: Testicular cancer is the most common malignancy of young males. Limited reports describe perioperative and long-term outcomes after surgical resection of metastatic, cervical, non-seminomatous germ cell tumors (NSGCT). The objective of this study was to investigate the effectiveness and safety of cervical lymphadenectomy in the management of metastatic NSGCT. STUDY DESIGN: Retrospective case series. METHODS: A single institution, retrospective review from 1998 to 2020 of patients with metastatic NSGCT who underwent cervical lymphadenectomy was conducted. Clinicopathological, surgical, and postoperative data were collected and analyzed. RESULTS: Sixty-eight predominantly white (91.0%) male patients with mean age 33.0 ± 11.3 years were included. Most (82.2%) presented with stage III disease at initial diagnosis. All patients had undergone primary platinum-based chemotherapy 1.0 to 22.7 months prior to selective ND. Surgery mainly involved nodal levels III (67.6%), IV (92.6%) and/or Vb (77.9%) and was frequently performed with concomitant thoracoabdominal NSGCT resections (63.2%). Cervical specimens predominantly revealed mature teratoma (83.8%) as solitary (69.1%) or component of mixed (14.7%) NSGCT. Ten (14.7%) perioperative complications occurred as vocal cord paresis (n = 6) from thoracic surgery and chyle leakage (n = 4). All resolved conservatively except two vocal cord paralyzes that required surgical repair due to tumor involvement of vagus nerve. Six instances of cervical recurrence occurred at median 12.5 (range, 5.8-38.6) months from ND, all re-demonstrating purely mature teratoma. The two-year cervical, non-cervical, and overall recurrence-free survivals were 83%, 55%, and 55%, respectively. Two-year disease-free and overall survivals were both 93%. CONCLUSIONS: Selective neck dissection is a safe, effective method for managing cervical NSGCT metastases. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1528-1534, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Nwosu OI, Jones AJ, Alwani M, et al. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases. Laryngoscope. 2021. PMID: 33421136. doi:10.1002/lary.29364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。